Shionogi Completes Acquisition of IntraBio and Adds AQNEURSA
AQNEURSA (levacetylleucine) is approved in the U.S. and Europe for neurological manifestations of Niemann-Pick disease.
AQNEURSA (levacetylleucine) is approved in the U.S. and Europe for neurological manifestations of Niemann-Pick disease.